Romiti GF, Corica B, Pipitone E, et al. Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients. Eur Heart J. 2021;42(35):3541–54. https://doi.org/10.1093/eurheartj/ehab453.

Article  PubMed  Google Scholar 

Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–32. https://doi.org/10.1183/09031936.06.00124605.

Article  CAS  PubMed  Google Scholar 

Safiri S, Carson-Chahhoud K, Noori M, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990–2019: Results from the global burden of disease study 2019. BMJ. 2022. https://doi.org/10.1136/bmj-2021-069679.

Article  PubMed  PubMed Central  Google Scholar 

Adatia A, Wahab M, Shahid I, et al. Effects of cigarette smoke exposure on pulmonary physiology, muscle strength and exercise capacity in a retrospective cohort with 30,000 subjects. PLOS ONE. 2021. https://doi.org/10.1371/journal.pone.0250957.

Article  PubMed  PubMed Central  Google Scholar 

2023 Gold Report—Global initiative for chronic obstructive lung disease. 2023. GOLD. https://goldcopd.org/2023-gold-report-2/. Accessed 1 Aug 2023.

Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;184(6):662–71. https://doi.org/10.1164/rccm.201104-0597oc.

Article  PubMed  Google Scholar 

Gutiérrez Villegas C, Paz-Zulueta M, Herrero-Montes M, Parás-Bravo P, Madrazo Pérez M. Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review. Health Econ Rev. 2021. https://doi.org/10.1186/s13561-021-00329-9.

Article  PubMed  PubMed Central  Google Scholar 

Johnson KM, Bryan S, Ghanbarian S, Sin DD, Sadatsafavi M. Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res. 2018. https://doi.org/10.1186/s12931-018-0731-1.

Article  PubMed  PubMed Central  Google Scholar 

Kjarsgaard M, Adatia A, Bhalla A, et al. Underestimation of airway luminal eosinophilia by quantitative sputum cytometry. Allergy Asthma Clin Immunol. 2021. https://doi.org/10.1186/s13223-021-00567-w.

Article  PubMed  PubMed Central  Google Scholar 

Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173(10):1114–21. https://doi.org/10.1164/rccm.200506-859oc.

Article  PubMed  Google Scholar 

Palikhe NS, Niven M, Fuhr D, et al. Low immunoglobulin levels affect the course of COPD in hospitalized patients. Allergy Asthma Clin Immunol. 2023. https://doi.org/10.1186/s13223-023-00762-x.

Article  PubMed  PubMed Central  Google Scholar 

Holm AM, Andreassen SL, Christensen VL, et al. Hypogammaglobulinemia and risk of exacerbation and mortality in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2015;15:799–807. https://doi.org/10.2147/copd.s236656.

Article  CAS  Google Scholar 

Leitao Filho FS, Ra SW, Mattman A, et al. Serum IGG subclass levels and risk of exacerbations and hospitalizations in patients with COPD. Respir Res. 2018. https://doi.org/10.1186/s12931-018-0733-z.

Article  PubMed  PubMed Central  Google Scholar 

Leitao Filho FS, Ra SW, Mattman A, et al. Serum IGG and risk of exacerbations and hospitalizations in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2017. https://doi.org/10.1016/j.jaci.2017.01.046.

Article  PubMed  Google Scholar 

Jolles S, Orange JS, Gardulf A, et al. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clin Exp Immunol. 2015;179(2):146–60. https://doi.org/10.1111/cei.12485.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cowan J, Mulpuru S, Alvarez G, Corrales-Medina V, Cameron DW. Chronic obstructive pulmonary disease exacerbation frequency and serum IGG Levels. J Allergy Clin Immunol. 2018;141(2):830–1. https://doi.org/10.1016/j.jaci.2017.09.036.

Article  PubMed  Google Scholar 

Moore BB, Moore TA, Toews GB. Role of T- and B-lymphocytes in pulmonary host defences. Eur Respir J. 2001;18(5):846–56. https://doi.org/10.1183/09031936.01.00229001.

Article  CAS  PubMed  Google Scholar 

Prevot J, Jolles S. Global immunoglobulin supply: Steaming towards the iceberg? Curr Opin Allergy Clin Immunol. 2020;20(6):557–64. https://doi.org/10.1097/aci.0000000000000696.

Article  PubMed  PubMed Central  Google Scholar 

Compagno N, Malipiero G, Cinetto F, Agostini C. Immunoglobulin replacement therapy in secondary hypogammaglobulinemia. Front Immunol. 2014. https://doi.org/10.3389/fimmu.2014.00626.

Article  PubMed  PubMed Central  Google Scholar 

Mouthon L, Lortholary O. Intravenous immunoglobulins in infectious diseases: where do we stand? Clin Microbiol Infect. 2003;9(5):333–8. https://doi.org/10.1046/j.1469-0691.2003.00694.x.

Article  CAS  PubMed  Google Scholar 

Ritchie B, Martins KJB, Tran DT, et al. Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study. Allergy Asthma Clin Immunol. 2022. https://doi.org/10.1186/s13223-022-00735-6.

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, et al. The Prisma 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021. https://doi.org/10.1136/bmj.n71.

Article  PubMed  PubMed Central  Google Scholar 

Julian HP, Savović J, Page MJ et al. 2023. Chapter 8: assessing risk of bias in a randomized trial. Cochrane Training. https://training.cochrane.org/handbook/current/chapter-08. Accessed 1 Aug 2023.

Study Quality Assessment Tools. 2021. NHLBI. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed 1 Aug 2023.

Campbell M, McKenzie JE, Sowden A, et al. Synthesis without meta-analysis (SWIM) in systematic reviews: reporting guideline. BMJ. 2020;368:l6890. https://doi.org/10.1136/bmj.l6890.

Article  PubMed  PubMed Central  Google Scholar 

Alachkar H, Anwar MA. The clinical effectiveness of immunoglobulin infusion therapy in specific antibody deficiency (SAD). J Clin Immunol. 2014. https://doi.org/10.1007/s10875-014-0101-9.

Article  Google Scholar 

Barth JM, Jaeger D, Broder M. Is there a benefit of an additive standard immunoglobulin therapy for the clinical course of COPD patients under chronic immunosuppressive therapy? Eur Resp J. 2001;16(Suppl. 31). https://www.ers-education.org/lr/show-details/?idP=28766

Zhu J, Wan X. Role of immunoglobulin in treating chronic obstructive pulmonary disease with fungal infection. Chinese J Infect Control. 2014. https://doi.org/10.3969/j.issn.1671-9638.2014.05.007.

Article  Google Scholar 

Gracia J, Vendrell M, Alvarez A, et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int Immunopharmacol. 2004;4(6):745–53. https://doi.org/10.1016/j.intimp.2004.02.011.

Article  CAS  PubMed  Google Scholar 

van Kessel DA, Hoffman TW, Velzen-Blad H, et al. Long-term clinical outcome of antibody replacement therapy in humoral immunodeficient adults with respiratory tract infections. EBioMedicine. 2017;18:254–60. https://doi.org/10.1016/j.ebiom.2017.03.025.

Article  PubMed  PubMed Central  Google Scholar 

Stein MR, Koterba A, Rodden L, Berger M. Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases. Postgrad M J. 2011;123(5):186–93. https://doi.org/10.3810/pgm.2011.09.2474.

Article  Google Scholar 

Baleeiro C, Mull N. Prevalence of common variable immunodeficiency (CVID) among patients with recurrent respiratory tract infections. Am J Respir Crit Care Med. 2010. https://doi.org/10.1164/ajrccm-conference.2010.181.1_MeetingAbstracts.A3187.

Article  Google Scholar 

Cowan J, Gaudet L, Mulpuru S, et al. A retrospective longitudinal within-subject risk interval analysis of immunoglobulin treatment for recurrent acute exacerbation of chronic obstructive pulmonary disease. PloS ONE. 2015. https://doi.org/10.1371/journal.pone.0142205.

Article  PubMed  PubMed Central  Google Scholar 

McCullagh BN, Comellas AP, Ballas ZK, Newell JD, Zimmerman MB, Azar AE. Antibody deficiency in patients with frequent exacerbations of chronic obstructive pulmonary disease (COPD). PloS ONE. 2017. https://doi.org/10.1371/journal.pone.0172437.

Article  PubMed  PubMed Central  Google Scholar 

Cowan J, Mulpuru S, Abdallah SJ, et al. A randomized double-blind placebo-control feasibility trial of immunoglobulin treatment for prevention of recurrent acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2021;16:3275–84. https://doi.org/10.2147/copd.s338849.

Article  PubMed  PubMed Central  Google Scholar 

Mathioudakis AG, Sivapalan P, Papi A, Vestbo J. The disentangling chronic obstructive pulmonary disease exacerbations clinical trials network (DECODE-net): Rationale and vision. Eur Respir J. 2020;56(1):2000627. https://doi.org/10.1183/13993003.00627-2020.

Article  PubMed  Google Scholar 

Alexander GM, Fekri A, Alvar A, et al. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations. ERJ. 2022;59(5):2102006.

Article  Google Scholar 

Mathioudakis AG, Moberg M, Janner J, Alonso-Coello P, Vestbo J. Outcomes reported on the management fo COPD exacerbations: a systematic survey of randomised controlled trials. ERJ Open Res. 2019;5(2):00072–2019. https://doi.org/10.1183/23120541.00072-2019.